The developmental failure of mammalian parthenogenote has been a mystery for a long time and posed a question as to why bi-parental reproduction is necessary for development to term. In the 1980s, it was proven that this failure was not due to the genetic information itself, but to epigenetic modification of genomic DNA. In the following decade, several studies successfully identified imprinted genes which were differentially expressed in a parent-of-origin-specific manner, and it was shown that the differential expression depended on the pattern of DNA methylation. These facts prompted development of genome-wide systematic screening methods based on DNA methylation and differential gene expression to identify imprinted genes. Recently computational approaches and microarray technology have been introduced to identify imprinted genes/loci, contributing to the expansion of our knowledge. However, it has been shown that the gene silencing derived from genomic imprinting is accomplished by several mechanisms in addition to direct DNA methylation, indicating that novel approaches are further required for comprehensive understanding of genomic imprinting. To unveil the mechanism of developmental failure in mammalian parthenogenote, systematic screenings for imprinted genes/loci have been developed. In this review, we describe genomic imprinting focusing on the history of genome-wide screening.

1.
Barlow DP, Stöger R, Herrmann BG, Saito K, Schweifer N: The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349:84–87 (1991).
2.
Bartolomei MS, Zemel S, Tilghman SM: Parental imprinting of the mouse H19 gene. Nature 351:153–155 (1991).
3.
Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ, et al: Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120:169–181 (2005).
4.
Buck MJ, Lieb JD: ChIP-chip: considerations for the design, analysis, and application of genome-wide chromatin immunoprecipitation experiments. Genomics 83:349–360 (2004).
5.
Cattanach BM, Kirk M: Differential activity of maternally and paternally derived chromosome regions in mice. Nature 315:496–498 (1985).
6.
Chapman V, Forrester L, Sanford J, Hastie N, Rossant J: Cell lineage-specific undermethylation of mouse repetitive DNA. Nature 307:284–286 (1984).
7.
Charalambous M, Smith FM, Bennett WR, Crew TE, Mackenzie F, Ward A: Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2-independent mechanism. Proc Natl Acad Sci USA 100:8292–8297 (2003).
8.
Charlier C, Segers K, Wagenaar D, Karim L, Berghmans S, Jaillon O, Shay T, Weissenbach J, Cockett N, Gyapay G, Georges M: Human-ovine comparative sequencing of a 250-kb imprinted domain encompassing the callipyge (clpg) locus and identification of six imprinted transcripts: DLK1, DAT, GTL2, PEG11, antiPEG11, and MEG8. Genome Res 11:850–862 (2001).
9.
Constância M, Pickard B, Kelsey G, Reik W: Imprinting mechanisms. Genome Res 8:881–900 (1998).
10.
Cross SH, Charlton JA, Nan X, Bird AP: Purification of CpG islands using a methylated DNA binding column. Nat Genet 6:236–244 (1994).
11.
DeChiara TM, Efstratiadis A, Robertson EJ: A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78–80 (1990).
12.
DeChiara TM, Robertson EJ, Efstratiadis A: Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849–859 (1991).
13.
Dowell RD, Jokerst RM, Day A, Eddy SR, Stein L: The distributed annotation system. BMC Bioinformatics 2:7 (2001).
14.
Falls JG, Pulford DJ, Wylie AA, Jirtle RL: Genomic imprinting: implications for human disease. Am J Pathol 154:635–647 (1999).
15.
Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89:1827–1831 (1992).
16.
Gardiner-Garden M, Frommer M: CpG islands in vertebrate genomes. J Mol Biol 196:261–282 (1987).
17.
Giddings SJ, King CD, Harman KW, Flood JF, Carnaghi LR: Allele specific inactivation of insulin 1 and 2, in the mouse yolk sac, indicates imprinting. Nat Genet 6:310–313 (1994).
18.
Glenn CC, Nicholls RD, Robinson WP, Saitoh S, Niikawa N, Schinzel A, Horsthemke B, Driscoll DJ: Modification of 15q11→q13 DNA methylation imprints in unique Angelman and Prader-Willi patients. Hum Mol Genet 2:1377–1382 (1993).
19.
Greally JM: Short interspersed transposable elements (SINEs) are excluded from imprinted regions in the human genome. Proc Natl Acad Sci USA 99:327–332 (2002).
20.
Gregory SG, Sekhon M, Schein J, Zhao S, Osoegawa K, Scott CE, Evans RS, Burridge PW, et al: A physical map of the mouse genome. Nature 418:743–750 (2002).
21.
Guillemot F, Caspary T, Tilghman SM, Copeland NG, Gilbert DJ, Jenkins NA, Anderson DJ, Joyner AL, Rossant J, Nagy A: Genomic imprinting of Mash2, a mouse gene required for trophoblast development. Nat Genet 9:235–242 (1995).
22.
Hagiwara Y, Hirai M, Nishiyama K, Kanazawa I, Ueda T, Sakaki Y, Ito T: Screening for imprinted genes by allelic message display: identification of a paternally expressed gene Impact on mouse chromosome 18. Proc Natl Acad Sci USA 94:9249–9254 (1997).
23.
Hatada I, Hayashizaki Y, Hirotsune S, Komatsubara H, Mukai T: A genomic scanning method for higher organisms using restriction sites as landmarks. Proc Natl Acad Sci USA 88:9523–9527 (1991).
24.
Hayashizaki Y, Hirotsune S, Okazaki Y, Hatada I, Shibata H, Kawai J, et al: Restriction landmark genomic scanning method and its various applications. Electrophoresis 14:251–258 (1993).
25.
Hayashizaki Y, Shibata H, Hirotsune S, Sugino H, Okazaki Y, Sasaki N, et al: Identification of an imprinted U2af binding protein related sequence on mouse chromosome 11 using the RLGS method. Nat Genet 6:33–40 (1994).
26.
Hirotsune S, Shibata H, Okazaki Y, Sugino H, Imoto H, Sasaki N, et al: Molecular cloning of polymorphic markers on RLGS gel using the spot target cloning method. Biochem Biophys Res Commun 194:1406–1412 (1993).
27.
Hubbard T, Andrews D, Caccamo M, Cameron G, Chen Y, Clamp M, et al: Ensembl 2005. Nucleic Acids Res 33:D447–453 (2005).
28.
Kagitani F, Kuroiwa Y, Wakana S, Shiroishi T, Miyoshi N, Kobayashi S, Nishida M, Kohda T, Kaneko-Ishino T, Ishino F: Peg5/Neuronatin is an imprinted gene located on sub-distal chromosome 2 in the mouse. Nucleic Acids Res 25:3428–3432 (1997).
29.
Kamiya M, Judson H, Okazaki Y, Kusakabe M, Muramatsu M, Takada S, Takagi N, Arima T, Wake N, Kamimura K, Satomura K, Hermann R, Bonthron DT, Hayashizaki Y: The cell cycle control gene ZAC/PLAGL1 is imprinted – a strong candidate gene for transient neonatal diabetes. Hum Mol Genet 9:453–460 (2000).
30.
Kaneda A, Takai D, Kaminishi M, Okochi E, Ushijima T: Methylation-sensitive representational difference analysis and its application to cancer research. Ann NY Acad Sci 983:131–141 (2003).
31.
Kaneko-Ishino T, Kuroiwa Y, Miyoshi N, Kohda T, Suzuki R, Yokoyama M, Viville S, Barton SC, Ishino F, Surani MA: Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization. Nat Genet 11:52–59 (1995).
32.
Kaufman MH, Barton SC, Surani MA: Normal postimplantation development of mouse parthenogenetic embryos to the forelimb bud stage. Nature 265:53–55 (1977).
33.
Kawai J, Hirotsune S, Hirose K, Fushiki S, Watanabe S, Hayashizaki Y: Methylation profiles of genomic DNA of mouse developmental brain detected by restriction landmark genomic scanning (RLGS) method. Nucleic Acids Res 21:5604–5608 (1993).
34.
Kawai J, Hirose K, Fushiki S, Hirotsune S, Ozawa N, Hara A, Hayashizaki Y, Watanabe S: Comparison of DNA methylation patterns among mouse cell lines by restriction landmark genomic scanning. Mol Cell Biol 14:7421–7427 (1994).
35.
Kawai J, Shinagawa A, Shibata K, Yoshino M, Itoh M, Ishii Y, et al: Functional annotation of a full-length mouse cDNA collection. Nature 409:685–690 (2001).
36.
Ke X, Thomas NS, Robinson DO, Collins A: A novel approach for identifying candidate imprinted genes through sequence analysis of imprint ed and control genes. Hum Genet 111:511–520 (2002).
37.
Kelsey G, Bodle D, Miller HJ, Beechey CV, Coombes C, Peters J, Williamson CM: Identification of imprinted loci by methylation-sensitive representational difference analysis: application to mouse distal chromosome 2. Genomics 62:129–138 (1999).
38.
Kikyo N, Williamson CM, John RM, Barton SC, Beechey CV, Ball ST, Cattanach BM, Surani MA, Peters J: Genetic and functional analysis of neuronatin in mice with maternal or paternal duplication of distal Chr 2. Dev Biol 190:66–77 (1997).
39.
Kobayashi S, Wagatsuma H, Ono R, Ichikawa H, Yamazaki M, Tashiro H, et al: Mouse Peg9/Dlk1 and human PEG9/DLK1 are paternally expressed imprinted genes closely located to the maternally expressed imprinted genes: mouse Meg3/Gtl2 and human MEG3. Genes Cells 5:1029–1037 (2000).
40.
Kobayashi S, Kohda T, Ichikawa H, Ogura A, Ohki M, Kaneko-Ishino T, Ishino F: Paternal expression of a novel imprinted gene, Peg12/Frat3, in the mouse 7C region homologous to the Prader-Willi syndrome region. Biochem Biophys Res Commun 290:403–408 (2002).
41.
Kohda T, Asai A, Kuroiwa Y, Kobayashi S, Aisaka K, Nagashima G, et al: Tumour suppressor activity of human imprinted gene PEG3 in a glioma cell line. Genes Cells 6:237–247 (2001).
42.
Kuroiwa Y, Kaneko-Ishino T, Kagitani F, Kohda T, Li LL, Tada M, et al: Peg3 imprinted gene on proximal chromosome 7 encodes for a zinc finger protein. Nat Genet 12:186–190 (1996).
43.
Lalande M: Parental imprinting and human disease. Annu Rev Genet 30:173–195 (1996).
44.
Ledbetter DH, Engel E: Uniparental disomy in humans: development of an imprinting map and its implications for prenatal diagnosis. Hum Mol Genet 4 Spec No:1757–1764 (1995).
45.
Lee MP, Hu RJ, Johnson LA, Feinberg AP: Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat Genet 15:181–185 (1997).
46.
Lefebvre L, Viville S, Barton SC, Ishino F, Keverne EB, Surani MA: Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest. Nat Genet 20:163–169 (1998).
47.
Lewis A, Murrell A: Genomic imprinting: CTCF protects the boundaries. Curr Biol 14:R284–286 (2004).
48.
Li L, Keverne EB, Aparicio SA, Ishino F, Barton SC, Surani MA: Regulation of maternal behavior and offspring growth by paternally expressed Peg3. Science 284:330–333 (1999).
49.
Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967–971 (1992).
50.
Lindsay S, Bird AP: Use of restriction enzymes to detect potential gene sequences in mammalian DNA. Nature 327:336–338 (1987).
51.
Lisitsyn N, Lisitsyn N, Wigler M: Cloning the differences between two complex genomes. Science 259:946–951 (1993).
52.
Luedi PP, Hartemink AJ, Jirtle RL: Genome-wide prediction of imprinted murine genes. Genome Res 15:875–884 (2005).
53.
McGrath J, Solter D: Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 37:179–183 (1984).
54.
McPherson JD, Marra M, Hillier L, Waterston RH, Chinwalla A, Wallis J, et al: A physical map of the human genome. Nature 409:934–941 (2001).
55.
Miyoshi N, Kuroiwa Y, Kohda T, Shitara H, Yonekawa H, Kawabe T, Hasegawa H, Barton SC, Surani MA, Kaneko-Ishino T, Ishino F: Identification of the Meg1/Grb10 imprinted gene on mouse proximal chromosome 11, a candidate for the Silver-Russell syndrome gene. Proc Natl Acad Sci USA 95:1102–1107 (1998).
56.
Miyoshi N, Wagatsuma H, Wakana S, Shiroishi T, Nomura M, Aisaka K, Kohda T, Surani MA, Kaneko-Ishino T, Ishino F: Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells 5:211–220 (2000).
57.
Mizuno Y, Sotomaru Y, Katsuzawa Y, Kono T, Meguro M, Oshimura M, et al: Asb4, Ata3, and Dcn are novel imprinted genes identified by high-throughput screening using RIKEN cDNA microarray. Biochem Biophys Res Commun 290:1499–1505 (2002).
58.
Morison IM, Paton CJ, Cleverley SD: The imprinted gene and parent-of-origin effect database. Nucleic Acids Res 29:275–276 (2001).
59.
Mukhopadhyay R, Yu W, Whitehead J, Xu J, Lezcano M, Pack S, et al: The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide. Genome Res 14:1594–1602 (2004).
60.
Nikaido I, Saito C, Mizuno Y, Meguro M, Bono H, Kadomura M, et al: Discovery of imprinted transcripts in the mouse transcriptome using large-scale expression profiling. Genome Res 13:1402–1409 (2003).
61.
Nikaido I, Saito C, Wakamoto A, Tomaru Y, Arakawa T, Hayashizaki Y, Okazaki Y: EICO (Expression-based Imprint Candidate Organizer): finding disease-related imprinted genes. Nucleic Acids Res 32:D548–551 (2004).
62.
Ohlsson R, Renkawitz R, Lobanenkov V: CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet 17:520–527 (2001).
63.
Okamura K, Sakaki Y, Ito T: Comparative genomics approach toward critical determinants for the imprinting of an evolutionarily conserved gene Impact. Biochem Biophys Res Commun 329:824–830 (2005).
64.
Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S, et al: Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 420:563–573 (2002).
65.
Onyango P, Miller W, Lehoczky J, Leung CT, Birren B, Wheelan S, Dewar K, Feinberg AP: Sequence and comparative analysis of the mouse 1-megabase region orthologous to the human 11p15 imprinted domain. Genome Res 10:1697–1710 (2000).
66.
Peters J, Wroe SF, Wells CA, Miller HJ, Bodle D, Beechey CV, Williamson CM, Kelsey G: A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2. Proc Natl Acad Sci USA 96:3830–3835 (1999).
67.
Plass C, Shibata H, Kalcheva I, Mullins L, Kotelevtseva N, Mullins J, et al: Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet 14:106–109 (1996).
68.
Razin A, Riggs AD: DNA methylation and gene function. Science 210:604–610 (1980).
69.
Razin A, Webb C, Szyf M, Yisraeli J, Rosenthal A, Naveh-Many T, Sciaky-Gallili N, Cedar H: Variations in DNA methylation during mouse cell differentiation in vivo and in vitro. Proc Natl Acad Sci USA 81:2275–2279 (1984).
70.
Reed ML, Leff SE: Maternal imprinting of human SNRPN, a gene deleted in Prader-Willi syndrome. Nat Genet 6:163–167 (1994).
71.
Reik W, Collick A, Norris ML, Barton SC, Surani MA: Genomic imprinting determines methylation of parental alleles in transgenic mice. Nature 328:248–251 (1987).
72.
Rush LJ, Plass C: Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications. Anal Biochem 307:191–201 (2002).
73.
Sapienza C, Peterson AC, Rossant J, Balling R: Degree of methylation of transgenes is dependent on gamete of origin. Nature 328:251–254 (1987).
74.
Schmidt JV, Matteson PG, Jones BK, Guan XJ, Tilghman SM: The Dlk1 and Gtl2 genes are linked and reciprocally imprinted. Genes Dev 14:1997–2002 (2000).
75.
Selker EU, Tountas NA, Cross SH, Margolin BS, Murphy JG, Bird AP, Freitag M: The methylated component of the Neurospora crassa genome. Nature 422:893–897 (2003).
76.
Shiura H, Miyoshi N, Konishi A, Wakisaka-Saito N, Suzuki R, Muguruma K, Kohda T, Wakana S, Yokoyama M, Ishino F, Kaneko-Ishino T: Meg1/Grb10 overexpression causes postnatal growth retardation and insulin resistance via negative modulation of the IGF1R and IR cascades. Biochem Biophys Res Commun 329:909–916 (2005).
77.
Smiraglia DJ, Frühwald MC, Costello JF, McCormick SP, Dai Z, Peltomäki P, O’Dorisio MS, Cavenee WK, Plass C: A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels. Genomics 58:254–262 (1999).
78.
Smith RJ, Dean W, Konfortova G, Kelsey G: Identification of novel imprinted genes in a genome-wide screen for maternal methylation. Genome Res 13:558–569 (2003).
79.
Strain L, Warner JP, Johnston T, Bonthron DT: A human parthenogenetic chimaera. Nat Genet 11:164–169 (1995).
80.
Strichman-Almashanu LZ, Lee RS, Onyango PO, Perlman E, Flam F, Frieman MB, Feinberg AP: A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. Genome Res 12:543–554 (2002).
81.
Surani MA, Barton SC, Norris ML: Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 308:548–550 (1984).
82.
Sutcliffe JS, Nakao M, Christian S, Örstavik KH, Tommerup N, Ledbetter DH, Beaudet AL: Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat Genet 8:52–58 (1994).
83.
Suzuki H, Kawai J, Taga C, Ozawa N, Watanabe S: A PCR-mediated method for cloning spot DNA on restriction landmark genomic scanning (RLGS) gel. DNA Res 1:245–250 (1994).
84.
Swain JL, Stewart TA, Leder P: Parental legacy determines methylation and expression of an autosomal transgene: a molecular mechanism for parental imprinting. Cell 50:719–727 (1987).
85.
Tilghman SM: The sins of the fathers and mothers: genomic imprinting in mammalian development. Cell 96:185–193 (1999).
86.
Villar AJ, Pedersen RA: Parental imprinting of the Mas protooncogene in mouse. Nat Genet 8:373–379 (1994).
87.
Walter J, Paulsen M: Imprinting and disease. Semin Cell Dev Biol 14:101–110 (2003).
88.
Wevrick R, Kerns JA, Francke U: Identification of a novel paternally expressed gene in the Prader-Willi syndrome region. Hum Mol Genet 3:1877–1882 (1994).
89.
Winking H, Silver LM: Characterization of a recombinant mouse T haplotype that expresses a dominant lethal maternal effect. Genetics 108:1013–1020 (1984).
90.
Yamada Y, Watanabe H, Miura F, Soejima H, Uchiyama M, Iwasaka T, Mukai T, Sakaki Y, Ito T: A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q. Genome Res 14:247–266 (2004).
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.